Page 3 - Kelli Luginbuhl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kelli luginbuhl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kelli Luginbuhl Today - Breaking & Trending Today

Female-led Duke biotech spinout Isolere Bio closes $7M in seed funding

by Chantal Allam May 5, 2021 .
DURHAM – Isolere Bio, a Duke University, female-led spinout focused on “reimagining the manufacturing of complex therapeutics,” has landed $7 million in seed funding from lead investor Northpond Ventures.
It’s now getting ready to scale.
“We are thrilled to be teaming up with a top-tier, science-driven investor who believes in and shares our mission of delivering technologies for a healthier and safer world,” said Kelli Luginbuhl, Ph.D., Isolere’s founder and CEO.
The funding will support “development, scaleup, and commercialization” of its most advanced purification technology platform.
Kelli Luginbuhl, Ph.D., Isolere’s founder and CEO ....

North Carolina , United States , Duke University , Isolere Isotag , Kelli Luginbuhl , Adam Wieschhaus , Ashutosh Chilkoti , Joe Mcmahon , Isolere Bio , Carolina Biotech Center , National Institutes Of Health , Chilkoti Laboratory At Duke University , National Science Foundation , Chilkoti Laboratory , National Institutes , North Carolina Biotech , வடக்கு கரோலினா , ஒன்றுபட்டது மாநிலங்களில் , டியூக் பல்கலைக்கழகம் , கெல்லி லுகிண்புல் , ஓஹோ மக்மேயந் , கரோலினா பயோடெக் மையம் , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , தேசிய அறிவியல் அடித்தளம் , தேசிய நிறுவனங்கள் , வடக்கு கரோலினா பயோடெக் ,

Ultrasensitive, rapid diagnostic detects Ebola earlier than gold standard test

Credit: Michaela Kane, Duke University
DURHAM, N.C. An interdisciplinary team of scientists at Duke University has developed a highly sensitive and rapid diagnostic test for Ebola virus (EBOV) infection. In monkeys infected with Ebola, this diagnostic, called the D4-assay, proved to be 1000 times more sensitive than the currently approved rapid diagnostic test and capable of detecting the virus a full day earlier than the gold standard polymerase chain reaction (PCR) test.
This work, which appears in
Science Translational Medicine on April 7, was done by biomedical engineers, molecular biologists, and immunologists at Duke University, and the University of Texas Medical Branch in Galveston and the Galveston National Laboratory. ....

Sierra Leone , Democratic Republic Of The Congo , Aiwei Yan , Cassio Fontes , Thomas Geisbert , Jacob Heggestad , Daniela Cruz , Angus Hucknall , Stephanie Foster , Ahsutosh Chilkoti , Carl Pieper , Jason Liu , Kelli Luginbuhl , Garrett Kelly , Patricia Shi , Daniel Joh , Michael Gunn , Alanl Kaganov , Ashutosh Chilkoti , Maiken Mikkelson , Duke University School Of Medicine , Human Services , National Institutes Of Health , Galveston National Laboratory , Department Of Health , Immucor Inc Norcross ,